GeneOnline’s Top 10 Headlines of the Year
It has been a year to remember. A year that has reminded us of the dangers of negligence and how little lapses can trigger a global crisis of massive proportions. …
Read MoreTag: SARS-CoV-2
COVID-19: Oxford/AstraZeneca’s DNA Vaccine Scores Emergency Use Approval in the UK
December 30th, 2020 – After a long and dark year of multiple waves of the COVID-19 outbreak, the first vaccines made it to the market in December 2020. In the …
Read More
New COVID-19 Variant: Vaccine Makers Optimistic but Experts are Cautious over Unique Mutations
Just when nations worldwide would have anticipated ending the year on a high with the recently approved COVID-19 vaccines, a new fast-spreading coronavirus variant, named B.1.1.7 (VUI-202012/01) has debuted on …
Read More
UK Braces for Increasing COVID-19 Cases Caused by Fast-Spreading Coronavirus Variant
After being a cataclysmic year for global health and economy, it seemed 2020 would end on a positive note with emergency use approvals for COVID-19 vaccines and the commencement of …
Read More
Moderna’s COVID-19 Vaccine Bags FDA’s Emergency Use Authorization, Inoculations to Start on Monday
December 18th, 2020 – The Food and Drug Administration (FDA) authorized Moderna’s COVID-19 vaccine for emergency use on Friday in adults 18 years and older, making it the second vaccine …
Read More
FDA Green Lights Very First COVID-19 Vaccine in the US
December 11, 2020 – Today marks a historic moment in the fight against the COVID-19 pandemic as the US Food and Drug Administration (FDA) approved Pfizer and BioNTech’s coronavirus vaccine, …
Read More
COVID-19: BioNTech Commences Phase 2 Vaccine Trials in China with Fosun
BioNTech, once a frontrunner in the global vaccine race, gained emergency approval in the UK recently. As the mRNA vaccine (BNT162b2), co-developed with Pfizer, is found more than 95% effective …
Read More
UK Becomes First Country to Approve Pfizer/BioNTech’s COVID-19 Vaccine
December 2, 2020 – In a major breakthrough in the COVID-19 vaccine race, the Medicines & Healthcare Products Regulatory Agency (MHRA) of the United Kingdom has given an emergency authorization …
Read More
Moderna Files for USFDA Authorization After Achieving 94.1% Vaccine Efficacy
November 30, 2020 – Moderna released the final results of its 30,000 participants vaccine trial in a press release today. The company said that its vaccine showed similarly high efficacy …
Read More
Russian Vaccine Makers Nudge AstraZeneca to Combine COVID-19 Vaccine, AZD1222 with Sputnik V
Russia has claimed that its COVID-19 vaccine, Sputnik V is 92% effective at protecting people from COVID-19, based on an interim analysis of trial results. Sputnik V is the world’s …
Read More